Gyros’ revolutionary Gyrolab platform was the product of years of work by
teams of dedicated scientists and technicians.
Gyros launches Gyrolab xPlore ™, a single-CD, compact alternative to Gyrolab™ xP workstation, giving laboratories application flexibility and the agility to develop assays more quickly and increase data quality with reduced hands-on time.
EMD Millipore launches five biomarker kits for use on Gyros’ immunoassay platforms.
Gyros launches Gyrolab™ Protein A Kit for efficient quantification of residual protein A.
Gyros partners with EMD Millipore to develop, manufacture and commercialize immunoassay kits for the Gyrolab platform.
The installed base of Gyrolab workstations continues to grow. MPI Research becomes the first contract research organization in North America to secure a second Gyrolab xP workstation.
By its 10th anniversary, Gyros has installed more than 75 Gyrolab workstations around the world.
Gyros launches Gyrolab xP with 21 CFR part-11 compliance and extended validation support.
Cambridge Antibody Technology (CAT) purchases a Gyrolab Bioaffy instrument. CAT is regarded as the jewel in the crown of British biotechnology and is subsequently acquired by AstraZeneca, which also has several Gyros´ instruments.
Gyrolab wins the Frost & Sullivan ‘Laboratory Automation Excellence in Technology of the Year Award’.
Gyros commences a collaboration with Fujirebio to develop diagnostic tests.
Gyros makes a move into biopharma with Gyrolab Bioaffy 200 CD for nanoliter-scale protein quantification of biomarkers.
The Bioaffy technology is presented for the first time, at the CHI conference Pep Talk: Protein Arrays in San Diego, in January.
Gyros AB launches their first product – Gyrolab MALDI SP1 – for purifying protein samples for analysis by MALDI mass spectrometry.
Gyros collaborates with a number of other vendors to explore new applications for CD-based microfluidics.
Gyros AB is founded, spinning off from Amersham Pharmacia Biotech.
Amersham Pharmacia Biotech and Åmic have filed more than 15 patent applications, covering cell-based assays and DNA sample prep and sequencing.
Åmic AB is founded in Uppsala, specializing in molding microstructures in plastic. Amersham Pharmacia Biotech is its major customer.
The exploratory research department at Amersham Pharmacia Biotech in Uppsala, Sweden, has been working on miniaturization and microfluidics, on and off, for nearly 10 years.